NCT07325006 Impact of Physician Behavior on Cancer Distress
| NCT ID | NCT07325006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2030-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2025-11-24 with a primary completion date of 2030-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This evaluates the impact of physician behaviors and other factors experienced during radiation treatment influence distress levels in cancer patients.
Eligibility Criteria
Inclusion Criteria: * Adult (age 18+ years old) * Must have a diagnosis of neoplasm * Must be actively undergoing radiation therapy (RT) or have completed RT within the last month at Mayo Clinic in Rochester * Able to read and write in English * Must have email and Mayo Clinic patient portal access Exclusion Criteria: * Patients who have not yet started RT * Patients who have been seen in consultation but not recommended for radiation
Contact & Investigator
May Elbanna, MB, BCh, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07325006 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325006 currently recruiting?
Yes, NCT07325006 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT07325006 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07325006 clinical trial?
NCT07325006 is sponsored by Mayo Clinic. The principal investigator is May Elbanna, MB, BCh, PhD at Mayo Clinic. The trial plans to enroll 5,000 participants.